HARVARD BIOSCIENCE, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
HARVARD BIOSCIENCE, INC. (HBIO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $3.18 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-03-13
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $3.96, a 50.57% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $2.63, a 5.40% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2022-03-31 was $2.78, a 30.67% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2021-03-31 was $4.01.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $3.18, a 33.61% increase from fiscal 2023.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $2.38, a 9.85% decline from fiscal 2022.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $2.64, a 29.97% decline from fiscal 2021.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2021 was $3.77, a 4.31% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $3.18 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | $3.18 10-Q · filed 2024-11-08 | ||||
| 2024-06-30 | $3.58 10-Q · filed 2024-08-08 | ||||
| 2024-03-31 | $3.96 10-Q · filed 2024-05-07 | ||||
| 2023-12-31 | $2.38 10-K · filed 2025-03-14 | ||||
| 2023-09-30 | $2.38 10-Q · filed 2023-11-07 | ||||
| 2023-06-30 | $2.38 10-Q · filed 2023-08-08 | ||||
| 2023-03-31 | $2.63 10-Q · filed 2023-04-26 | ||||
| 2022-12-31 | $2.64 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | $2.64 10-Q · filed 2022-11-09 | ||||
| 2022-06-30 | $2.72 10-Q · filed 2022-08-04 | ||||
| 2022-03-31 | $2.78 10-Q · filed 2022-05-04 | ||||
| 2021-12-31 | $3.77 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $3.78 10-Q · filed 2021-11-05 | ||||
| 2021-06-30 | $3.76 10-Q · filed 2021-08-06 | ||||
| 2021-03-31 | $4.01 10-Q · filed 2021-05-07 | ||||
| 2020-12-31 | $3.94 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $2.56 10-Q · filed 2020-11-06 | ||||
| 2020-06-30 | $2.56 10-Q · filed 2020-08-10 | ||||
| 2019-12-31 | $2.98 10-K/A · filed 2021-03-17 | ||||
| 2019-09-30 | $3.25 10-Q · filed 2019-11-08 | ||||
| 2019-06-30 | $3.25 10-Q · filed 2019-08-08 | ||||
| 2019-03-31 | $3.25 10-Q · filed 2019-05-08 | ||||
| 2018-12-31 | $2.98 10-K · filed 2020-03-16 | $3.50 10-K · filed 2019-03-18 | |||
| 2018-09-30 | $3.50 10-Q · filed 2018-11-01 | ||||
| 2018-06-30 | $2.83 10-Q · filed 2018-08-02 | ||||
| 2018-03-31 | $3.06 10-Q · filed 2018-05-10 | ||||
| 2017-12-31 | $3.50 10-K · filed 2020-03-16 | $2.48 10-K · filed 2018-03-16 | |||
| 2017-09-30 | $2.49 10-Q · filed 2017-11-02 | ||||
| 2017-06-30 | $2.56 10-Q · filed 2017-08-03 | ||||
| 2017-03-31 | $2.56 10-Q · filed 2017-05-08 | ||||
| 2016-12-31 | $2.80 10-K · filed 2018-03-16 | ||||
| 2016-09-30 | $2.80 10-Q · filed 2016-11-03 | ||||
| 2016-06-30 | $2.83 10-Q · filed 2016-08-04 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-16 | ||||
| 2015-12-31 | $3.04 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $3.04 10-Q · filed 2015-11-05 | ||||
| 2015-06-30 | $3.04 10-Q · filed 2015-08-06 | ||||
| 2015-03-31 | $2.95 10-Q · filed 2015-05-07 | ||||
| 2014-12-31 | $3.08 10-K · filed 2017-03-17 | ||||
| 2014-09-30 | $3.00 10-Q · filed 2014-11-06 | ||||
| 2014-06-30 | $3.13 10-Q · filed 2014-08-07 | ||||
| 2014-03-31 | $3.27 10-Q · filed 2014-05-08 | ||||
| 2013-12-31 | $3.20 10-K · filed 2016-04-29 | ||||
| 2013-09-30 | $5.47 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | $5.39 10-Q · filed 2013-08-09 | ||||
| 2013-03-31 | -$5.42 10-Q · filed 2013-05-10 | ||||
| 2012-12-31 | $3.94 10-K · filed 2015-03-12 | ||||
| 2011-12-31 | $3.79 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |